These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 8658174)
61. Underestimate of HIV reservoirs threatens purging approach. Dolgin E Nat Med; 2013 Apr; 19(4):384-5. PubMed ID: 23558610 [No Abstract] [Full Text] [Related]
62. Cytotoxic T-cell activity and progression of HIV disease: abstract and commentary. Lederman MM; Valdez H JAMA; 1998 Jan; 279(3):242. PubMed ID: 9438750 [No Abstract] [Full Text] [Related]
63. The New York case: lessons being learned. Volberding PA Ann Intern Med; 2005 May; 142(10):866-8. PubMed ID: 15845950 [No Abstract] [Full Text] [Related]
64. HIV-I infection and cellular metabolism. De Simone C; Famularo G; Cifone G; Mitsuya H Immunol Today; 1996 Jun; 17(6):256-8. PubMed ID: 8962626 [No Abstract] [Full Text] [Related]
65. HIV. Genetic effects on immunity immunity to infection. Web alert. Greaves DR Curr Opin Immunol; 1998 Aug; 10(4):377-8. PubMed ID: 9722910 [No Abstract] [Full Text] [Related]
66. Cell-Associated HIV-1 Unspliced-to-Multiply-Spliced RNA Ratio at 12 Weeks of ART Predicts Immune Reconstitution on Therapy. Scherpenisse M; Kootstra NA; Bakker M; Berkhout B; Pasternak AO mBio; 2021 Mar; 12(2):. PubMed ID: 33688002 [TBL] [Abstract][Full Text] [Related]
67. Cell-associated HIV RNA: a dynamic biomarker of viral persistence. Pasternak AO; Lukashov VV; Berkhout B Retrovirology; 2013 Apr; 10():41. PubMed ID: 23587031 [TBL] [Abstract][Full Text] [Related]
68. Engineering antigen-specific T cells from genetically modified human hematopoietic stem cells in immunodeficient mice. Kitchen SG; Bennett M; Galić Z; Kim J; Xu Q; Young A; Lieberman A; Joseph A; Goldstein H; Ng H; Yang O; Zack JA PLoS One; 2009 Dec; 4(12):e8208. PubMed ID: 19997617 [TBL] [Abstract][Full Text] [Related]
69. Lentiviral vectors encoding human immunodeficiency virus type 1 (HIV-1)-specific T-cell receptor genes efficiently convert peripheral blood CD8 T lymphocytes into cytotoxic T lymphocytes with potent in vitro and in vivo HIV-1-specific inhibitory activity. Joseph A; Zheng JH; Follenzi A; Dilorenzo T; Sango K; Hyman J; Chen K; Piechocka-Trocha A; Brander C; Hooijberg E; Vignali DA; Walker BD; Goldstein H J Virol; 2008 Mar; 82(6):3078-89. PubMed ID: 18184707 [TBL] [Abstract][Full Text] [Related]
70. Novel inhibitory effects of gamma-glutamylcysteine ethyl ester against human immunodeficiency virus type 1 production and propagation. Kubota S; Shetty S; Zhang H; Kitahara S; Pomerantz RJ Antimicrob Agents Chemother; 1998 May; 42(5):1200-6. PubMed ID: 9593150 [TBL] [Abstract][Full Text] [Related]
71. Dynamics of HIV-1 mRNA expression in patients with long-term nonprogressive HIV-1 infection. Comar M; Simonelli C; Zanussi S; Paoli P; Vaccher E; Tirelli U; Giacca M J Clin Invest; 1997 Aug; 100(4):893-903. PubMed ID: 9259589 [TBL] [Abstract][Full Text] [Related]